Developer docs
API playgroundTry for free, no card

Search company profiles

ZimVie

Full company profile

uuid0003sdf

Namestring
ZimVie
Legal namestring
ZimVie Inc.
Websiteurl
zimvie.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

ZimVie is a dental implantology company that develops, manufactures, and markets a comprehensive portfolio of dental implant systems, digital dentistry software, surgical instrumentation, biomaterials, and restorative components used in tooth replacement and restoration procedures. Founded in March 2022 as a spin-off of the dental and spine business units from Zimmer Biomet Holdings, the company is headquartered in Westminster, Colorado, and serves dental professionals, dental laboratories, and dental service organizations through wholly-owned operating subsidiaries in North America, Europe, the Middle East, and the Asia Pacific region, with end-customer reach in more than 70 countries.

The product architecture is a platform-plus-modules model anchored by proprietary implant systems including TSX, T3 PRO, T3, Osseotite, Trabecular Metal, and Eztetic, supported by the RealGUIDE digital dentistry software suite for guided surgery planning, the BellaTek CAD/CAM abutment line, and biomaterials such as the Puros allograft, RegenerOss bone graft, Biotivity membrane, and OsseoGuard product families. Manufacturing and CAD/CAM capabilities reside in wholly-owned subsidiaries including Zfx GmbH (Germany), Zimmer Dental Inc., Biomet 3i, LLC, and Implant Concierge, LLC. The firm holds multiple FDA 510(k) clearances and operates trademarked sub-brands across implant, restorative, and digital categories.

ZimVie generates revenue primarily through direct enterprise sales to dental professionals and oral surgeons, complemented by exclusive distribution agreements in key international markets (notably the Osstem Implant partnership covering 90+ Chinese cities) and a direct-to-dental-practice eServices online platform for product ordering. Pricing is quote-based rather than publicly disclosed. On October 20, 2025, healthcare-focused private equity firm ARCHIMED completed a $730 million acquisition of ZimVie at $19 per share, taking the company private and delisting it from NASDAQ, with the stated intent of accelerating growth in the global dental implant market.

Short descriptiontext

ZimVie develops and markets dental implant systems, guided surgery software, biomaterials, and restorative components for tooth replacement and restoration, serving dental professionals, laboratories, and dental service organizations in more than 70 countries under a platform-plus-modules architecture anchored by the TSX and T3 implant franchises and the RealGUIDE digital dentistry suite.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersPalm Beach Gardens, United States
HQ citystring
Palm Beach Gardens
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices13 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
dental implant systems, guided implant surgery, dental biomaterials, restorative components, digital dentistry software
Industry5 codes
1Dental Implants & Prosthodontic Components (Implants/Abutments/Prosthetics)
CodeHLAHAEAEPrimaryYes
2Dental Implant Surgery & Bone Grafting
CodeHLABAEABPrimaryNo
3Implant Prosthodontics (Implant-Supported Restorations)
CodeHLABAFACPrimaryNo
4Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM)
CodeHLAHAEAGPrimaryNo
5Implant Prosthetics & Abutment Fabrication
CodeHLABAJACPrimaryNo
NAICS code3 codes
  • Dental Equipment and Supplies Manufacturing339114
  • Surgical Appliance and Supplies Manufacturing339113
  • Dental Laboratories339116
SIC code3 codes
  • Dental Equipment & Supplies3843
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Dental Implants and Restorative Solutions
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Dental Implant Systems
TypeHardware Sales
Description

Sale of dental implant systems including TSX, TSV, T3 PRO, T3, Eztetic, Trabecular Metal, and Osseotite implant lines along with surgical kits and instruments.

zimvie.com
2Biomaterials
TypeHardware Sales
Description

Sale of bone graft materials, membranes, and regenerative instrumentation for dental surgical procedures, including Puros, RegenerOss, and OsseoGuard product lines.

zimvie.com
3Restorative Products
TypeHardware Sales
Description

Sale of prosthetic components, abutments, and restorative solutions compatible with various implant systems including GenTek, BellaTek, and Azure product lines.

zimvie.com
4Digital Dentistry Software
TypeSubscription Recurring
Description

Sale of RealGUIDE CAD/CAM software modules for digital implant planning and surgical guide design in dental practices.

openpr.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1Azure™ Dental
Description

Multi-platform prosthetic solutions brand

zimvie.com
+8 more records
Core offering1 text field

ZimVie develops, manufactures, and sells dental implant systems, biomaterials, restorative prosthetic components, and digital dentistry software for guided implant surgery. Its portfolio includes TSX, T3 PRO, T3, Osseotite, Trabecular Metal, and Eztetic implant lines, supported by RealGUIDE CAD/CAM planning software, surgical kits, allograft bone graft materials, membranes, and the GenTek restorative components platform, sold to dental professionals and dental laboratories globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Immediate extraction and standard loading protocols with enhanced placement predictability
+1 more record
Product overview1 text field

ZimVie is a life sciences company providing a comprehensive dental implant and restoration portfolio. The offering is a platform-plus-modules architecture built around core implant systems (TSX, T3 PRO, T3, Osseotite, Trabecular Metal, Eztetic, TSV, SwissPlus, T3 Short, Immediate Molar) supported by digital workflow solutions including the RealGUIDE Software Suite and Implant Concierge for guided surgery planning. The product ecosystem includes surgical kits (TSX Modular Surgical Kit, T3 PRO Modular Surgical Kit), restorative components (GenTek Genuine Restorative Components, Azure Multi-Platform prosthetic solutions), biomaterials (Puros allografts, RegenerOss bone graft materials, Biotivity membranes), and digital solutions (BellaTek CAD/CAM abutments, Encode empowered laboratories, Medit scanner integration). This integrated approach enables dental professionals to perform implant planning, surgical placement, and prosthetic restoration using compatible components across the ZimVie portfolio.

Product and service3 records
1TSX Dental Implant System
CategoryDental Implant Systems
Description

Next-generation dental implant engineered for immediate extraction and standard loading protocols with enhanced placement predictability, available in Japan and the U.S. market.

2T3 PRO Tapered Dental Implant
CategoryDental Implant Systems
Description

Advanced tapered dental implant designed for precision-driven surgical performance and reliable osseointegration.

3T3 Dental Implant
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-07-23
Description

ZimVie announced a strategic distribution agreement with Osstem Implant for the Chinese dental implant market. Osstem has exclusive commercial responsibility for ZimVie's implant systems across its distribution network in over 90 Chinese cities. Osstem Implant, founded in South Korea in 1997, is the world's largest dental implant manufacturer. The partnership aims to offer more choices to Chinese dental customers and patients.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global leader in dental implants and restorative solutions. Straumann competes head-to-head with ZimVie across premium implant systems (Bone Level, BLX, TLX), digital workflows (coDiagnostix, SmileCloud), and biomaterials. Straumann is the global market leader and the primary direct competitor.

TypeBroad incumbent
Description

Large diversified dental equipment and consumables company with Ankylos and Xive implant lines among its portfolio. Broader scope than ZimVie (chairs, imaging, CAD/CAM, implants), but directly competes in implants and digital workflow. Comparable customer base of dental practices.

TypeDirect peer
Description

US-based premium dental implant company (Tapered Pro, Tapered Internal, Laser-Lok) owned by Henry Schein. Directly comparable product category and customer base to ZimVie's T3 PRO and TSX lines. Comparable biomaterial portfolio and digital workflow approach.

TypeDirect peer
Description

World's largest dental implant manufacturer by volume, headquartered in South Korea. Direct competitor with proprietary implant systems (TS, ET), and simultaneously ZimVie's exclusive distribution partner in China. Comparable product breadth and global commercial presence.

TypeDirect peer
Description

Holds Nobel Biocare, the second-largest premium dental implant brand globally (N1, TiUltra, Xeal). Direct overlap with ZimVie in implant systems, digital planning (DTX Studio), and restorative components. Comparable distribution model and target customer base of dental professionals and specialists.

TypeDirect peer
Description

Straumann-owned Brazilian dental implant company targeting the value and mid-tier segments (Helix, Acqua, Zi). Direct competitor to ZimVie's Eztetic and Osseotite lines, particularly in Latin America and value-conscious markets.

TypeEmerging player
Description

US-based dental implant manufacturer offering distinctive plate-form/short implant designs. Smaller scale than ZimVie but overlapping customer base of dental professionals seeking specialty implant solutions. Comparable product category.

TypeEmerging player
Description

Mid-sized dental implant and biomaterials company (Prima, Genesis, Paltop). Privately held and PE-backed (Nordic Capital). Comparable product scope to ZimVie in implants and regenerative biomaterials, with overlapping customer base of dental professionals.

TypeDirect peer
Description

Israeli implant manufacturer (V3, C1, Seven) offering premium implants at competitive price points. Owned by Dentsply Sirona. Direct overlap with ZimVie in implant systems and digital workflow tools targeting general dentists and specialists.

TypeBroad incumbent
Description

Largest dental distributor in North America, also owns BioHorizons and CAMLOG implant brands. Indirect competitor as a distribution channel for ZimVie's products, while owning competing implant brands. Overlapping customer base of dental practices.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ZimVie

Dental Implants and Restorative Solutionszimvie.com

ZimVie develops and markets dental implant systems, guided surgery software, biomaterials, and restorative components for tooth replacement and restoration, serving dental professionals, laboratories, and dental service organizations in more than 70 countries under a platform-plus-modules architecture anchored by the TSX and T3 implant franchises and the RealGUIDE digital dentistry suite.

What ZimVie does

ZimVie is a dental implantology company that develops, manufactures, and markets a comprehensive portfolio of dental implant systems, digital dentistry software, surgical instrumentation, biomaterials, and restorative components used in tooth replacement and restoration procedures. Founded in March 2022 as a spin-off of the dental and spine business units from Zimmer Biomet Holdings, the company is headquartered in Westminster, Colorado, and serves dental professionals, dental laboratories, and dental service organizations through wholly-owned operating subsidiaries in North America, Europe, the Middle East, and the Asia Pacific region, with end-customer reach in more than 70 countries.

The product architecture is a platform-plus-modules model anchored by proprietary implant systems including TSX, T3 PRO, T3, Osseotite, Trabecular Metal, and Eztetic, supported by the RealGUIDE digital dentistry software suite for guided surgery planning, the BellaTek CAD/CAM abutment line, and biomaterials such as the Puros allograft, RegenerOss bone graft, Biotivity membrane, and OsseoGuard product families. Manufacturing and CAD/CAM capabilities reside in wholly-owned subsidiaries including Zfx GmbH (Germany), Zimmer Dental Inc., Biomet 3i, LLC, and Implant Concierge, LLC. The firm holds multiple FDA 510(k) clearances and operates trademarked sub-brands across implant, restorative, and digital categories.

ZimVie generates revenue primarily through direct enterprise sales to dental professionals and oral surgeons, complemented by exclusive distribution agreements in key international markets (notably the Osstem Implant partnership covering 90+ Chinese cities) and a direct-to-dental-practice eServices online platform for product ordering. Pricing is quote-based rather than publicly disclosed. On October 20, 2025, healthcare-focused private equity firm ARCHIMED completed a $730 million acquisition of ZimVie at $19 per share, taking the company private and delisting it from NASDAQ, with the stated intent of accelerating growth in the global dental implant market.

ZimVie firmographics

Firmographics
Name
ZimVie
Legal name
ZimVie Inc.
Website
https://zimvie.com
Company type
Private
Founded year
2022
Operating status
Acquired
Headcount range
1,001–5,000 employees
Short description
ZimVie develops and markets dental implant systems, guided surgery software, biomaterials, and restorative components for tooth replacement and restoration, serving dental professionals, laboratories, and dental service organizations in more than 70 countries under a platform-plus-modules architecture anchored by the TSX and T3 implant franchises and the RealGUIDE digital dentistry suite.
Ownership category
akta.pro rank

ZimVie industry classification

Industry
Product category
Dental Implants and Restorative Solutions
NAICS
Dental Equipment and Supplies Manufacturing (339114), Surgical Appliance and Supplies Manufacturing (339113), Dental Laboratories (339116)
SIC
Dental Equipment & Supplies (3843), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Dental Implants & Prosthodontic Components (Implants/Abutments/Prosthetics) (HLAHAEAE)
akta.pro secondary industries
Dental Implant Surgery & Bone Grafting (HLABAEAB), Implant Prosthodontics (Implant-Supported Restorations) (HLABAFAC), Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG), Implant Prosthetics & Abutment Fabrication (HLABAJAC)

Keywords

  • Dental implant systems
  • Guided implant surgery
  • Dental biomaterials
  • Restorative components
  • Digital dentistry software

Where ZimVie is headquartered

Location

Headquarters

HQ city
Palm Beach Gardens
HQ country
United States
HQ region
North America

Offices13 records

Markets served

ZimVie business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Dental Implant Systems: Sale of dental implant systems including TSX, TSV, T3 PRO, T3, Eztetic, Trabecular Metal, and Osseotite implant lines along with surgical kits and instruments.
  2. Biomaterials: Sale of bone graft materials, membranes, and regenerative instrumentation for dental surgical procedures, including Puros, RegenerOss, and OsseoGuard product lines.
  3. Restorative Products: Sale of prosthetic components, abutments, and restorative solutions compatible with various implant systems including GenTek, BellaTek, and Azure product lines.
  4. Digital Dentistry Software: Sale of RealGUIDE CAD/CAM software modules for digital implant planning and surgical guide design in dental practices.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

ZimVie product offering

Product offering

Core offering

ZimVie develops, manufactures, and sells dental implant systems, biomaterials, restorative prosthetic components, and digital dentistry software for guided implant surgery. Its portfolio includes TSX, T3 PRO, T3, Osseotite, Trabecular Metal, and Eztetic implant lines, supported by RealGUIDE CAD/CAM planning software, surgical kits, allograft bone graft materials, membranes, and the GenTek restorative components platform, sold to dental professionals and dental laboratories globally.

Product overview

ZimVie is a life sciences company providing a comprehensive dental implant and restoration portfolio. The offering is a platform-plus-modules architecture built around core implant systems (TSX, T3 PRO, T3, Osseotite, Trabecular Metal, Eztetic, TSV, SwissPlus, T3 Short, Immediate Molar) supported by digital workflow solutions including the RealGUIDE Software Suite and Implant Concierge for guided surgery planning. The product ecosystem includes surgical kits (TSX Modular Surgical Kit, T3 PRO Modular Surgical Kit), restorative components (GenTek Genuine Restorative Components, Azure Multi-Platform prosthetic solutions), biomaterials (Puros allografts, RegenerOss bone graft materials, Biotivity membranes), and digital solutions (BellaTek CAD/CAM abutments, Encode empowered laboratories, Medit scanner integration). This integrated approach enables dental professionals to perform implant planning, surgical placement, and prosthetic restoration using compatible components across the ZimVie portfolio.

Differentiator

Problem solved

Functional benefit

Brands

  • Azure™ Dental: Multi-platform prosthetic solutions brand
  • RealGUIDE®
  • Implant Concierge®
  • GenTek®
  • BellaTek®
  • Puros®
  • T3 PRO®
  • TSX®
  • Zfx™

Products and services

  • TSX Dental Implant System Next-generation dental implant engineered for immediate extraction and standard loading protocols with enhanced placement predictability, available in Japan and the U.S. market.
  • T3 PRO Tapered Dental Implant Advanced tapered dental implant designed for precision-driven surgical performance and reliable osseointegration.
  • T3 Dental Implant

Quantifiable outcome

  • Immediate extraction and standard loading protocols with enhanced placement predictability
  • +1 more outcomes

Companies that use ZimVie

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

ZimVie technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

ZimVie partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Osstem Implant Co., Ltd.coreChannel Partner/ Reseller/ Distributor · 23 July 2025ZimVie announced a strategic distribution agreement with Osstem Implant for the Chinese dental implant market. Osstem has exclusive commercial responsibility for ZimVie's implant systems across its distribution network in over 90 Chinese cities. Osstem Implant, founded in South Korea in 1997, is the world's largest dental implant manufacturer. The partnership aims to offer more choices to Chinese dental customers and patients.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

ZimVie competitors and assessment

Company assessment

Direct peers

  • Straumann Group: Global leader in dental implants and restorative solutions. Straumann competes head-to-head with ZimVie across premium implant systems (Bone Level, BLX, TLX), digital workflows (coDiagnostix, SmileCloud), and biomaterials. Straumann is the global market leader and the primary direct competitor.
  • BioHorizons Implant Systems: US-based premium dental implant company (Tapered Pro, Tapered Internal, Laser-Lok) owned by Henry Schein. Directly comparable product category and customer base to ZimVie's T3 PRO and TSX lines. Comparable biomaterial portfolio and digital workflow approach.
  • Osstem Implant: World's largest dental implant manufacturer by volume, headquartered in South Korea. Direct competitor with proprietary implant systems (TS, ET), and simultaneously ZimVie's exclusive distribution partner in China. Comparable product breadth and global commercial presence.
  • Envista Holdings (Nobel Biocare): Holds Nobel Biocare, the second-largest premium dental implant brand globally (N1, TiUltra, Xeal). Direct overlap with ZimVie in implant systems, digital planning (DTX Studio), and restorative components. Comparable distribution model and target customer base of dental professionals and specialists.
  • Neodent: Straumann-owned Brazilian dental implant company targeting the value and mid-tier segments (Helix, Acqua, Zi). Direct competitor to ZimVie's Eztetic and Osseotite lines, particularly in Latin America and value-conscious markets.
  • MIS Implants Technologies: Israeli implant manufacturer (V3, C1, Seven) offering premium implants at competitive price points. Owned by Dentsply Sirona. Direct overlap with ZimVie in implant systems and digital workflow tools targeting general dentists and specialists.

Broad incumbents

  • Dentsply Sirona: Large diversified dental equipment and consumables company with Ankylos and Xive implant lines among its portfolio. Broader scope than ZimVie (chairs, imaging, CAD/CAM, implants), but directly competes in implants and digital workflow. Comparable customer base of dental practices.
  • Henry Schein: Largest dental distributor in North America, also owns BioHorizons and CAMLOG implant brands. Indirect competitor as a distribution channel for ZimVie's products, while owning competing implant brands. Overlapping customer base of dental practices.

Emerging players

  • Bicon Dental Implants: US-based dental implant manufacturer offering distinctive plate-form/short implant designs. Smaller scale than ZimVie but overlapping customer base of dental professionals seeking specialty implant solutions. Comparable product category.
  • Keystone Dental: Mid-sized dental implant and biomaterials company (Prima, Genesis, Paltop). Privately held and PE-backed (Nordic Capital). Comparable product scope to ZimVie in implants and regenerative biomaterials, with overlapping customer base of dental professionals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

ZimVie social profiles

Digital presence

ZimVie compliance and trust

Trust signal

Compliance3 records

ZimVie financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ZimVie leadership team

Management profile

Number of profiles

Profiles11 records

ZimVie subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

ZimVie funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ZimVie M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ZimVie

What does ZimVie do?

ZimVie develops, manufactures, and sells dental implant systems, biomaterials, restorative prosthetic components, and digital dentistry software for guided implant surgery. Its portfolio includes TSX, T3 PRO, T3, Osseotite, Trabecular Metal, and Eztetic implant lines, supported by RealGUIDE CAD/CAM planning software, surgical kits, allograft bone graft materials, membranes, and the GenTek restorative components platform, sold to dental professionals and dental laboratories globally.

Is ZimVie a public or private company?

ZimVie is a private company. It is classified as private equity controlled and is currently acquired.

When was ZimVie founded?

ZimVie was founded in 2022. It employs 1,001 to 5,000 people.

Where is ZimVie based?

ZimVie is headquartered in Palm Beach Gardens, United States, in the North America region.

How does ZimVie make money?

Four revenue lines are on record. Dental Implant Systems are the primary driver. The others are biomaterials, restorative Products and digital Dentistry Software.

Who are ZimVie's main competitors?

Direct peers on record are Straumann Group, BioHorizons Implant Systems, Osstem Implant, Envista Holdings (Nobel Biocare), Neodent and MIS Implants Technologies. Broad incumbents are Dentsply Sirona and Henry Schein. Emerging players are Bicon Dental Implants and Keystone Dental.

Does ZimVie have an API?

No public API is recorded for ZimVie.

What industry is ZimVie in?

ZimVie's product category is Dental Implants and Restorative Solutions. Its primary akta.pro industry code is HLAHAEAE, Dental Implants & Prosthodontic Components (Implants/Abutments/Prosthetics), with a secondary code of HLABAEAB, Dental Implant Surgery & Bone Grafting. Its NAICS code is 339114 and its SIC code is 3843.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireStraumann and Geistlich-Led Dental Implants and Bone Graft Markets Set for Strong Growth Through 2032 – iData ResearchThe global dental implant and final abutment market is projected to exceed $11 billion by 2032, up from over $7 billion in 2025, while the bone graft substitute market is expected to reach nearly $3.8 billion. Straumann led implants and Geistlich led bone grafts in 2025, with both markets driven by rising tooth loss and digital workflow adoption.뉴스톱MBK·UCK, ‘오스템’ 해외사업 키워 몸값 높인다 - 뉴스톱Ostem Implant, acquired by MBK and UCK, is expanding overseas after delisting. Q1 revenue was 328.4 billion won, with overseas sales at 68.1%. The company is building US production capacity and China distribution, aiming to boost value for future listing or sale.openPR.comDental Implants and Prosthetics Market to Reach USD 39.05 Billion by 2033 at 12.3% CAGR; North America Leads with 39.7% Share - Key Players: Dentsply Sirona, Straumann Group, ZimVie Inc.The global dental implants and prosthetics market is projected to reach USD 39.05 billion by 2033, growing at a CAGR of 12.3%, driven by increased prevalence of dental disorders and technological advancements. Leading companies such as Dentsply Sirona, Straumann Group, and ZimVie Inc. are actively expanding digital and implant solutions to capitalize on this growth.openPR.comLeading Companies Fueling Growth and Innovation in the Rendering and Simulation Software MarketSynopsys, Inc. acquired Ansys, Inc. in January 2025 for an undisclosed sum, aiming to expand its simulation and rendering portfolio across semiconductors, automotive, aerospace, and industrial applications by combining chip and system-level verification with multiphysics engineering simulation. The global rendering and simulation software market is projected to grow from $XX billion to $48.92 billion by 2030 at an 11.3% CAGR, driven by digital twin adoption, VR simulations, cloud-based rendering, and AI-driven simulation models. Additionally, ZimVie Inc. introduced new RealGUIDE CAD and FULL SUITE software modules in February 2023 for its digital dentistry platform.openPR.comFuture Perspectives: Key Trends Shaping the Computer Aided Design (CAD) Software Market Until 2030The global CAD software market is projected to reach $27.35 billion by 2030 with a compound annual growth rate of 5.9%, driven by cloud-based solutions, AI integration, virtual and augmented reality, and IoT convergence in smart manufacturing. In July 2025, US-based Synopsys Inc. acquired Ansys Inc. for approximately $35 billion to create an integrated platform spanning from silicon design to full systems, combining Synopsys' chip design tools with Ansys' simulation and analysis capabilities. Additionally, ZimVie, a US-based life sciences firm, launched the RealGUIDE CAD software suite in February 2023 for digital dentistry applications including implant planning and surgical guide design.openPR.comLeading Companies Solidifying Their Presence in the Dental Implants and Abutment Systems MarketThe dental implants and abutment systems market is projected to reach $9.18 billion by 2030, growing at a compound annual growth rate of 7.0%, driven by digital workflow adoption and demand for aesthetic dental restorations. In April 2023, Henry Schein acquired Brazil-based S.I.N. Implant System to strengthen its footprint in the global implant market. In February 2024, ZimVie launched its next-generation TSX dental implant in Japan, engineered for immediate extraction and standard loading protocols with enhanced placement predictability.BeckersdentalPrivate equity’s grip on dentistry: 11 movesThis article is a roundup of 11 private equity-related transactions in the dental industry from the current year, including acquisitions, strategic investments, and financing arrangements. Notable deals include Patient Square Capital's $4.1 billion acquisition of Patterson Companies and Archimed's acquisition of dental implant manufacturer ZimVie. The transactions involve dental service organizations, product manufacturers, and practice management companies across the United States, with involvement from multiple private equity and credit firms.Beckersdental5 dental deals totaling $785M+The article summarizes five dental industry acquisitions and real estate transactions reported since mid-September, totaling over $785 million. The largest deal is the acquisition of dental implant manufacturer ZimVie by Archimed for $730 million. The remaining four transactions include retail centers and practice buildings in Florida, Connecticut, and Colorado, ranging from $1.1 million to $44.5 million.openPR.comDental Implants Market to hit US$ 10.22 Billion by 2033 | Leading Companies 2025 - BioHorizons, Nobel Biocare Services AG, ZimVie Inc., OSSTEM IMPLANT CO., LTD., Institut Straumann AGThe global dental implants market is projected to grow from US$ 5.28 billion in 2024 to US$ 10.22 billion by 2033, a CAGR of 7.7%. Growth is driven by rising implant adoption, with only 6% of Americans currently having implants, expected to rise to 23% by 2026. High costs remain a restraint.GlobeNewswireZimVie Stockholders Vote to Approve Acquisition by ARCHIMEDZimVie stockholders approved the acquisition by an ARCHIMED affiliate at a special meeting on October 10, 2025. The merger is expected to close on October 20, 2025, subject to conditions in the agreement.